Institution statistics

Past rankings:

Ranking timeline:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

^*Ratio includes only projects with > 2 partners

Summary:

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Partners:

Constancy:

Subjects: Diversity index:1

Categories:

Project overview:

Start date	Project	acronym	role	funding	partners
2020-10-01	HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS	HARMONY PLUS	participant	6.715.625	39
2020-10-01	H2O Health Outcomes Observatory	H2O	participant	10.476.687	23
2020-05-01	EUbOPEN: Enabling and Unlocking biology in the OPEN	EUbOPEN	participant	27.935.000	22
2020-01-01	Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies	ImmUniverse	participant	15.500.000	26
2020-01-01	PharmaLedger	PharmaLedger	participant	8.290.694	28
2019-11-01	Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases	IDEA-FAST	participant	20.997.523	46
2019-11-01	EU Patient- cEntric clinicAl tRial pLatform	EU-PEARL	participant	12.004.953	36
2019-10-01	Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies	Immune-Image	participant	15.000.000	22
2019-09-01	Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions	3TR	participant	40.273.192	70
2019-09-01	Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials	Trials@Home	participant	19.036.998	31
2019-04-01	Biomarkers in Atopic Dermatitis and Psoriasis	BIOMAP	participant	10.500.000	32
2019-04-01	Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation	ConcePTION	participant	15.299.991	53
2019-04-01	Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement	MOBILISE-D	participant	25.395.897	34
2019-03-01	Neurotoxicity De-Risking in Preclinical Drug Discovery	NeuroDeRisk	participant	5.331.000	18
2019-03-01	EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells	EBiSC2	participant	4.599.648	16
2019-02-01	Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease	TransBioLine	participant	13.999.998	27
2019-01-01	Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain	IM2PACT	participant	9.000.000	27
2019-01-01	Vaccines and Infectious Diseases in the Ageing PopuLation	VITAL	participant	5.499.882	24
2018-11-01	European Health Data and Evidence Network	EHDEN	participant	14.105.750	22
2018-09-01	WEB-RADR 2	WEB-RADR 2	participant	1.168.750	11
2018-09-01	Ensuring the future of EUPATI beyond 2020	EFOEUPATI	participant	365.243	12
2018-07-01	Research empowerment on solute carriers (ReSOLUTE)	ReSOLUTE	participant	12.000.000	14
2018-05-01	Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production	iConsensus	participant	4.700.000	19
2018-05-01	conect4children (COllaborative Network for European Clinical Trials For Children)	c4c	participant	67.000.000	48
2018-03-01	Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.	PARADIGM	participant	4.498.931	34
2017-11-01	Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections	COMBACTE-CDI	participant	2.312.305	14
2017-11-01	Liver Investigation: Testing Marker Utility in Steatohepatitis	LITMUS	participant	15.797.881	56
2017-10-01	European Quality In Preclinical Data	EQIPD	participant	4.495.523	30
2017-09-01	Rheuma Tolerance for Cure	RTCure	participant	6.000.000	20
2017-02-01	Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055	DO-IT	participant	3.549.833	36
2017-01-01	Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106	IB4SD-TRISTAN	participant	12.000.000	21
2017-01-01	REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019	RESCEU	participant	14.498.125	18
2017-01-01	ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064	ITCC-P4	participant	7.370.000	21
2016-10-01	Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966	PREFER	participant	6.000.000	33
2016-04-01	Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916	PRISM	participant	8.080.000	23
2008-12-01	Combating incontinence, from basic science to clinical practice	INCOMB	participant	2.908.693	10